Mosaic ImmunoEngineering Inc.
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
9114 ADAMS AVE., HUNTINGTON BEACH, CA, 92646
Mailing Address
9114 ADAMS AVE., HUNTINGTON BEACH, CA, 92646
Phone
657-208-0890
Fiscal Year End
1231
EIN
841070278
Financial Overview
FY2025
-$5.87M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | April 15, 2026 | View on SEC |
| 10-Q Quarterly financial report | November 19, 2025 | View on SEC |
| 10-Q Quarterly financial report | August 19, 2025 | View on SEC |
| 10-Q Quarterly financial report | May 20, 2025 | View on SEC |
| 10-K Annual financial report | April 15, 2025 | View on SEC |
Annual Reports
10-K
April 15, 2026
- Company is actively seeking new transformative medical assets to build a pipeline.
- Management is resetting the business model following the expiration of the CPMV platform license.
Related Companies
Companies in the same industry (SIC: 2836)
Aura Biosciences, Inc.
AURA
Biological Products, (No Diagnostic Substances)
Adaptive Biotechnologies Corp
ADPT
Biological Products, (No Diagnostic Substances)
Vor Biopharma Inc.
VOR
Biological Products, (No Diagnostic Substances)
Abpro Holdings, Inc.
ABPO
Biological Products, (No Diagnostic Substances)
BioCardia, Inc.
BCDA
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.